Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2016

View Archived Issues

Phase III trial to establish biosimilarity of SB8 to bevacizumab

Sarepta Therapeutics initiates phase III trial of SRP-4045 and SRP-4053 for the treatment of DMD

FDA grants emergency use authorization for Zika virus molecular detection assay

GVK Biosciences patents TrKA inhibitors

Arvinas discloses PROTAC compounds

Johns Hopkins University describes agents for the treatment of cancer

Newave Pharmaceutical develops FGFR4 inhibitors

Oncbiomune Pharmaceuticals enrolls patients for phase Ia study of Proscavax

University of Washington presents micro-dystrophins

Antibe Therapeutics completes phase II trial of ATB-346

Lycera begins enrollment in phase II trial of LYC-30937-EC in active ulcerative colitis

Armanezumab shows promise for AD

Immune mechanisms of the Mtb deltappe25-pe19 vaccine candidate

BioLineRx collaborates with MD Anderson Cancer Center for phase II study of BL-8040

Windtree receives grant to support Aerosurf phase IIb trial

Valeant licenses rights to develop and commercialize NER-1006 from Norgine

Alkermes submits sNDA to FDA for extended-release formulation of Aristada

Coherus BioSciences reports topline results for phase III study of CHS-1420

Selumetinib does not meet primary endpoint in phase III SELECT-1 trial

Proteostasis Therapeutics completes key preclinical milestone in collaboration with Astellas

Scintilla Pharmaceuticals acquires Scilex Pharmaceuticals to bolster pain management business

COMP grants orphan drug designation to AB Science's masitinib in ALS

FDA confirms sufficient data to advance E-2609 into phase III studies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...